-
Something wrong with this record ?
Functional reorganization of monoamine transport systems during villous trophoblast differentiation: evidence of distinct differences between primary human trophoblasts and BeWo cells
V. Vachalova, R. Karahoda, M. Ottaviani, KY. Anandam, C. Abad, C. Albrecht, F. Staud
Language English Country England, Great Britain
Document type Journal Article
Grant support
20-13017S
Grantová Agentura České Republiky
20-13017S
Grantová Agentura České Republiky
20-13017S
Grantová Agentura České Republiky
20-13017S
Grantová Agentura České Republiky
20-13017S
Grantová Agentura České Republiky
NLK
BioMedCentral
from 2003-12-01
BioMedCentral Open Access
from 2003
Directory of Open Access Journals
from 2003
Free Medical Journals
from 2003
PubMed Central
from 2003
Europe PubMed Central
from 2003
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Medline Complete (EBSCOhost)
from 2003-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
Springer Nature OA/Free Journals
from 2003-12-01
- MeSH
- Dopamine metabolism MeSH
- Humans MeSH
- Norepinephrine pharmacology MeSH
- Placenta metabolism MeSH
- Serotonin * metabolism pharmacology MeSH
- Pregnancy MeSH
- Trophoblasts * metabolism MeSH
- Check Tag
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Three primary monoamines-serotonin, norepinephrine, and dopamine-play major roles in the placenta-fetal brain axis. Analogously to the brain, the placenta has transport mechanisms that actively take up these monoamines into trophoblast cells. These transporters are known to play important roles in the differentiated syncytiotrophoblast layer, but their status and activities in the undifferentiated, progenitor cytotrophoblast cells are not well understood. Thus, we have explored the cellular handling and regulation of monoamine transporters during the phenotypic transitioning of cytotrophoblasts along the villous pathway. METHODS: Experiments were conducted with two cellular models of syncytium development: primary trophoblast cells isolated from the human term placenta (PHT), and the choriocarcinoma-derived BeWo cell line. The gene and protein expression of membrane transporters for serotonin (SERT), norepinephrine (NET), dopamine (DAT), and organic cation transporter 3 (OCT3) was determined by quantitative PCR and Western blot analysis, respectively. Subsequently, the effect of trophoblast differentiation on transporter activity was analyzed by monoamine uptake into cells. RESULTS: We present multiple lines of evidence of changes in the transcriptional and functional regulation of monoamine transporters associated with trophoblast differentiation. These include enhancement of SERT and DAT gene and protein expression in BeWo cells. On the other hand, in PHT cells we report negative modulation of SERT, NET, and OCT3 protein expression. We show that OCT3 is the dominant monoamine transporter in PHT cells, and its main functional impact is on serotonin uptake, while passive transport strongly contributes to norepinephrine and dopamine uptake. Further, we show that a wide range of selective serotonin reuptake inhibitors affect serotonin cellular accumulation, at pharmacologically relevant drug concentrations, via their action on both OCT3 and SERT. Finally, we demonstrate that BeWo cells do not well reflect the molecular mechanisms and properties of healthy human trophoblast cells. CONCLUSIONS: Collectively, our findings provide insights into the regulation of monoamine transport during trophoblast differentiation and present important considerations regarding appropriate in vitro models for studying monoamine regulation in the placenta.
Institute of Biochemistry and Molecular Medicine University of Bern Bern Switzerland
Swiss National Centre of Competence in Research NCCR TransCure University of Bern Bern Switzerland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024913
- 003
- CZ-PrNML
- 005
- 20221031100051.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12958-022-00981-8 $2 doi
- 035 __
- $a (PubMed)35927731
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Vachalova, Veronika $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 245 10
- $a Functional reorganization of monoamine transport systems during villous trophoblast differentiation: evidence of distinct differences between primary human trophoblasts and BeWo cells / $c V. Vachalova, R. Karahoda, M. Ottaviani, KY. Anandam, C. Abad, C. Albrecht, F. Staud
- 520 9_
- $a BACKGROUND: Three primary monoamines-serotonin, norepinephrine, and dopamine-play major roles in the placenta-fetal brain axis. Analogously to the brain, the placenta has transport mechanisms that actively take up these monoamines into trophoblast cells. These transporters are known to play important roles in the differentiated syncytiotrophoblast layer, but their status and activities in the undifferentiated, progenitor cytotrophoblast cells are not well understood. Thus, we have explored the cellular handling and regulation of monoamine transporters during the phenotypic transitioning of cytotrophoblasts along the villous pathway. METHODS: Experiments were conducted with two cellular models of syncytium development: primary trophoblast cells isolated from the human term placenta (PHT), and the choriocarcinoma-derived BeWo cell line. The gene and protein expression of membrane transporters for serotonin (SERT), norepinephrine (NET), dopamine (DAT), and organic cation transporter 3 (OCT3) was determined by quantitative PCR and Western blot analysis, respectively. Subsequently, the effect of trophoblast differentiation on transporter activity was analyzed by monoamine uptake into cells. RESULTS: We present multiple lines of evidence of changes in the transcriptional and functional regulation of monoamine transporters associated with trophoblast differentiation. These include enhancement of SERT and DAT gene and protein expression in BeWo cells. On the other hand, in PHT cells we report negative modulation of SERT, NET, and OCT3 protein expression. We show that OCT3 is the dominant monoamine transporter in PHT cells, and its main functional impact is on serotonin uptake, while passive transport strongly contributes to norepinephrine and dopamine uptake. Further, we show that a wide range of selective serotonin reuptake inhibitors affect serotonin cellular accumulation, at pharmacologically relevant drug concentrations, via their action on both OCT3 and SERT. Finally, we demonstrate that BeWo cells do not well reflect the molecular mechanisms and properties of healthy human trophoblast cells. CONCLUSIONS: Collectively, our findings provide insights into the regulation of monoamine transport during trophoblast differentiation and present important considerations regarding appropriate in vitro models for studying monoamine regulation in the placenta.
- 650 _2
- $a dopamin $x metabolismus $7 D004298
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a noradrenalin $x farmakologie $7 D009638
- 650 _2
- $a placenta $x metabolismus $7 D010920
- 650 _2
- $a těhotenství $7 D011247
- 650 12
- $a serotonin $x metabolismus $x farmakologie $7 D012701
- 650 12
- $a trofoblasty $x metabolismus $7 D014327
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Karahoda, Rona $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Ottaviani, Martina $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Anandam, Kasin Yadunandam $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Abad, Cilia $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Albrecht, Christiane $u Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland $u Swiss National Centre of Competence in Research, NCCR TransCure, University of Bern, Bern, Switzerland
- 700 1_
- $a Staud, Frantisek $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. frantisek.staud@faf.cuni.cz
- 773 0_
- $w MED00008251 $t Reproductive biology and endocrinology $x 1477-7827 $g Roč. 20, č. 1 (2022), s. 112
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35927731 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100049 $b ABA008
- 999 __
- $a ok $b bmc $g 1854557 $s 1176203
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 20 $c 1 $d 112 $e 20220804 $i 1477-7827 $m Reproductive biology and endocrinology $n Reprod Biol Endocrinol $x MED00008251
- GRA __
- $a 20-13017S $p Grantová Agentura České Republiky
- GRA __
- $a 20-13017S $p Grantová Agentura České Republiky
- GRA __
- $a 20-13017S $p Grantová Agentura České Republiky
- GRA __
- $a 20-13017S $p Grantová Agentura České Republiky
- GRA __
- $a 20-13017S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20221017